<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180313039082N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-06-26</date_registration>
      <primary_sponsor>Ahvaz University of Medical Sciences</primary_sponsor>
      <public_title>The Effect of Group Cognitive-Behavioral Therapy(CBT) on Sleep disorders</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Group Cognitive-Behavioral Therapy(CBT) on Sleep disorders in Postmenopausal Women</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-04-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>46</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/30246</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: A randomized controlled trial with a control group, randomized, with a block allocation to the groups, Randomization description: In order to do the intervention, the women will be divided into two groups of 23 participant as control and intervention groups using block randomization with a block size of four and allocation ratio of one. For allocation concealment of women in the intervention and control groups, 23 4-digit even numbers will be chosen from random numbers as codes for participants of control group and 23 4-digit odd numbers for participants of intervention group will be chosen from random numbers table and they will be written according to the order of blocks. Then, the number of intervention and control groups will put in the opac envelops and then the envelops will be closed and they will be given randomly to the eligible women in the study by the secretary of menopause clinic (the researcher and the participant will not informed about allocation until the last moment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>sleep disorders in menopausal women.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:for this group 6 sessions of 90 minutes counseling of cognitive behavior therapy will be held weekly.The content of sessions will be as follow: First session: introduction and orientation with group members, concept of menopause and changes during menopause, concept of insomnia models, sleep restriction and controlling the stimulants.Second and third sessions: management of sleep health and therapeutic cognitive with the aim of modifying the dysfunctional beliefs about sleep and effects of insomnia on daily performance will be tought. Fourth and fifth sessions: cognitive-behavioral treatment principles will be reinforced, and the sleep program will be adjusted according to the information of daily sleep log report. Sixth session: it will be focused on prevention from relapse and skills to deal with failures. Intervention 2: Control group: For this group, participants will complete the sleep disorder questionnaires and they will receive the routine care at postmenopausal clinic of the Imam Khomeini Hospital in Ahvaz.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data will be shareable after making the patients unidentifiable.

When:
Start the access period one year after the publication

To whom:
Only for researchers working in academic and scientific institutions.

Conditions:
The data are accessible by mentioning the name of the investigator and for clinical and research actions.

Where to obtain:
Ms. Poorandokht Afshari. Faculty Member of Ahvaz Jundishapur University.
Email address: p_afshary@yahoo.com

How to obtain:
Send the request by email and respond as soon as possible

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Poorandokht Afshari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Menopause and Andropause Research Center, Faculty of Nursing and Midwifery, Jundishapur University of Medical Science,Golestan st.</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>61357-15794</zip>
        <telephone>+98 61 3373 8619</telephone>
        <email>p_afshary@yahoo.com</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Poorandokht Afshari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Menopause and Andropause Research Center, Faculty of Nursing and Midwifery, Jundishapur University of Medical Science,Golestan st. Ahvaz, Iran</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>61357-15794</zip>
        <telephone>+98 61 3373 8619</telephone>
        <email>p_afshary@yahoo.com</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Being at the age of 40- 60 years
Passing for at least one year and up to 5 years from menopause
Being married
Literacy at least at a high school education
Having sleep disorder, according to the Insomnia Severity Index and Pitsburg Sleep Quality questionnaire
Willingness to participate in this study and providing written consent</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>60 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Presence of medical problems Interfering with sleep disorders
Work at night shift
recent participation in psychotherapy or cognitive-behavioral therapy for other problems.
Recent severe trauma during the last three months
Taking sleeping and antipsychotics medications
Having mental illnesses such as severe depression and severe anxiety, that may leading to sleep problems
Smoking (more than 10 cigarettes a day), drug and alcohol use</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G47</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Sleep disorders</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:for this group 6 sessions of 90 minutes counseling of cognitive behavior therapy will be held weekly.The content of sessions will be as follow: First session: introduction and orientation with group members, concept of menopause and changes during menopause, concept of insomnia models, sleep restriction and controlling the stimulants.Second and third sessions: management of sleep health and therapeutic cognitive with the aim of modifying the dysfunctional beliefs about sleep and effects of insomnia on daily performance will be tought. Fourth and fifth sessions: cognitive-behavioral treatment principles will be reinforced, and the sleep program will be adjusted according to the information of daily sleep log report. Sixth session: it will be focused on prevention from relapse and skills to deal with failures.</i_keyword>
      <i_keyword>Control group: For this group, participants will complete the sleep disorder questionnaires and they will receive the routine care at postmenopausal clinic of the Imam Khomeini Hospital in Ahvaz.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Sleep disorders. Timepoint: Sleep disorders (at the beginning of the intervention), before the intervention, 3, 6, and 10 weeks after the intervention. Method of measurement: Insomnia Severity Index, Pitsburg Sleep Quality Index, Sleep Log.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Ahvaz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-04-21</approval_date>
        <contact_name>Ethics committee of Ahvaz Jundishapur University of Medical Sciences</contact_name>
        <contact_address>Ahvaz Jundishapur University Medical Science, Golestan Ave. Ahvaz Ahvaz Khouzestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
